The biggest retinoid news for October 2026 is wider over-the-counter access to a prescription-strength adapalene combination. Retinoids are vitamin A-based topicals that unclog pores, and new evidence supports fixed-dose combinations for better efficacy and tolerability. That shift matters for shoppers who want proven acne treatment without a prescription visit.
The U.S. Food and Drug Administration change covers teens and adults. Galderma reports FDA approval on May 22, 2026 for the prescription-to-OTC switch of Differin Epiduo Gel with adapalene 0.1% plus benzoyl peroxide 2.5% for acne ages 12 and older, in the Galderma approval announcement. Dermatology reviews from 2026 add practical detail on combinations, scarring, and who should avoid retinoids.
Medical information disclaimer: This article is for general educational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult a physician or other qualified health professional about symptoms, medications, tests, or treatment decisions.
Official resources:
- Explore the official data from FDA — Use this primary source to review the underlying data.
- Read the official notice from Galderma — Use this primary source to verify the official announcement.
Table of Contents
- What can you buy without a prescription now?
- How do dermatologists recommend using retinoids?
- Which new combinations show promise?
- When should you skip retinoids?
What can you buy without a prescription now?
Differin Epiduo Gel pairs adapalene 0.1% with benzoyl peroxide 2.5% in one product. Dermatology Times describes it as the first stable fixed-dose prescription acne product combining a retinoid with benzoyl peroxide, which clears clogged pores, kills acne bacteria and reduces inflammation to clear and prevent breakouts, in the Dermatology Times report on the approval. It is approved for acne in patients ages 12 and older.
The combination approach helps address several breakouts drivers at once. Adapalene keeps pores clear and calms inflammation. Benzoyl peroxide lowers acne bacteria on the skin.
- Check the label for adapalene 0.1% plus benzoyl peroxide 2.5%
- Use it for face acne starting at age 12
- Apply once daily as directed, plus sunscreen in the morning
- Stop and ask a clinician about severe burning, swelling, or spreading rash
How do dermatologists recommend using retinoids?
Current American Academy of Dermatology acne guidelines strongly recommend topical retinoids alone or in fixed-dose combinations. The Academy lists adapalene, tretinoin, tazarotene and trifarotene to unclog pores and reduce inflammation, affecting patients age 9 and older. Use is not limited to one acne type or one body site.
An April 2026 peer-reviewed review in Pharmaceuticals reaches a similar result. It concludes topical retinoids work for both noninflammatory and inflammatory acne. It also finds newer formulations and combining regimens with benzoyl peroxide or antibiotics improve efficacy and tolerability versus monotherapy.
Which new combinations show promise?
Researchers are testing multimodal topicals that pair retinoids with other actives. A June 2026 Journal of Drugs in Dermatology study reports a novel topical combining a retinoid with salicylic acid for moderate-to-severe acne. The goal is stronger clearing while managing irritation.
Another combination pairs clascoterone 1% with adapalene 0.3%. A 16-week study presented at Fall Clinical Dermatology Conference 2025 found reduced acne severity and improved quality of life with good tolerability, according to AJMC reporting on a Duke faculty presentation. The result supports retinoid-based combinations for moderate-to-severe acne.
When should you skip retinoids?
A 6-month randomized split-face trial in adults found daily tazarotene as effective as microneedling for atrophic post-acne scarring. That offers a practical non-procedural option for pitted scars. The single-center design limits generalizability, so results may differ in wider practice.
Pregnancy rules are stricter. The Pharmaceuticals review and FDA materials note systemic isotretinoin remains restricted to severe recalcitrant nodular acne under FDA REMS/iPLEDGE because it can cause birth defects, as described in the FDA prescriber guide for isotretinoin. Topical retinoids are generally avoided in pregnancy, with tazarotene contraindicated, so patients who are pregnant or planning pregnancy need non-retinoid alternatives.
You Might Also Like
- What Is New With Teen Acne in October 2026? Latest FDA and dermatology sources and Key Takeaways
- What Is New With Laser and Acne in October 2026? Latest FDA and dermatology sources and Key Takeaways
- What Is New With Hormonal and Acne in October 2026? Latest FDA and dermatology sources and Key Takeaways